retatrutide safety trial phase Nearly 30% average weight loss from a weekly injection., could represent the next New Product The weight loss medication Pack Type:Stick Packs (3 month/90 servings)

retatrutide safety trial phase Nearly 30% average weight loss from a weekly injection., could represent the next New Product The weight loss medication Pack Type:Stick Packs (3 month/90 servings)

The weight loss medication landscape just changed dramatically — and I mean dramatically. 🙌 We now have not one but TWO FDA-approved GLP-1 pills (no injections required). A triple-hormone agonist in clinical

Key TakeawaysGLP-1 drugs might lower the risk of dangerous blood clots and death among people with autoimmune diseasesPeople taking GLP-1 drugs were 44% less likely to dieThey also had a lower risk of blood clots in their lungs or causing a stroke.WEDNESDAY, June 17, 2026 (HealthDay News) — People with an autoimmune disease and obesity might lower their risk of dangerous blood clots and death by taking Ozempic or Zepbound, a new study says.Autoimmune diseases like celiac disease, vitiligo, psoriasis or rheumatoid arthritis increase the risk of severe heath emergencies because they cause inflammation and malfunctioning immune responses, researchers said.But GLP-1 medications might be able to counter that risk, researchers reported recently in the Journal of the American Heart Association.Overall, people’s risk of death was cut by nearly half if they were taking a GLP-1 drug, the study found.“In this real-world analysis, we found a consistent signal toward fewer serious complications including blood clots and lower mortality among patients treated with GLP-1 receptor agonists,” senior researcher Dr

New Product

Pack Type:Stick Packs (3 month/90 servings)

From an investing point of view, we'll look we know there's something like 110 or 20 compounds in development right now, for weight loss in the GLP, one and GLP one plus class, not all of those are going to come to market